Literature DB >> 2399898

A possible mechanism for neurologic ischemic events in patients with atrial septal aneurysm.

M Zabalgoitia-Reyes1, C Herrera, D K Gandhi, D J Mehlman, D D McPherson, J V Talano.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2399898     DOI： 10.1016/0002-9149(90)91146-w

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  7 in total

1.  Patent foramen ovale morphology and impact on percutaneous device closure.

Authors:  H G El Said; C J McMahon; C E Mullins; R H Pignatelli; R G Grifka; M R Nihill; J A Vincent
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

Review 2.  Current status of percutaneous PFO closure.

Authors:  N Rohrhoff; J P Vavalle; S Halim; T L Kiefer; J K Harrison
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

3.  Use of the reversed button device to treat an atrial septal aneurysm associated with a patent foramen ovale.

Authors:  V K Mehan; E B Sideris; B Meier
Journal:  Br Heart J       Date:  1995-11

Review 4.  Patent foramen ovale and stroke: what should be done?

Authors:  Marco R Di Tullio; Shunichi Homma
Journal:  Curr Opin Hematol       Date:  2009-09       Impact factor: 3.284

5.  Recurrent episodic hypoxaemic respiratory failure following a stroke.

Authors:  Aaron S C Foo; Zi Kheng Tan; Evelyn Lee; Nien Yue Koh
Journal:  BMJ Case Rep       Date:  2012-08-01

6.  Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4.

Authors:  Mahdi Moradi Marjaneh; Edwin P Kirk; Maximilian G Posch; Cemil Ozcelik; Felix Berger; Roland Hetzer; Robyn Otway; Tanya L Butler; Gillian M Blue; Lyn R Griffiths; Diane Fatkin; Jeremy J Martinson; David S Winlaw; Michael P Feneley; Richard P Harvey
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

7.  Echocardiographic Findings in Patients with Atrial Septal Aneurysm: A Prospective Case-Control Study.

Authors:  Ramazan Atak; Mehmet Ileri; Selcuk Ozturk; Ahmet Korkmaz; Ertan Yetkin
Journal:  Cardiol Res Pract       Date:  2019-04-01       Impact factor: 1.866
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.